Table 7. Patient death, relapse, and... | American Society of Hematology

Table 7.

Patient death, relapse, and aGVHD for DC1 and DC2

Outcome and DC level	No. of patients	No. of treatment failures	Survival after transplantation, %	P
Death
DC1				.0130
High	25	7	52.4^*
Low	25	16	35.6^*
DC2				.0740
High	18	5	58.0^*
Low	32	18	40.1^*
Relapse
DC1				.0434
High	25	5	79.3†
Low	25	11	44.3†
DC2				.0925
High	18	3	82.6†
Low	32	13	50.8†
aGVHD
DC1				.0002
High	25	12	51.7‡
Low	25	22	12.0‡
DC2				.0137
High	18	9	49.4‡
Low	32	25	21.9‡

Outcome and DC level	No. of patients	No. of treatment failures	Survival after transplantation, %	P
Death
DC1				.0130
High	25	7	52.4^*
Low	25	16	35.6^*
DC2				.0740
High	18	5	58.0^*
Low	32	18	40.1^*
Relapse
DC1				.0434
High	25	5	79.3†
Low	25	11	44.3†
DC2				.0925
High	18	3	82.6†
Low	32	13	50.8†
aGVHD
DC1				.0002
High	25	12	51.7‡
Low	25	22	12.0‡
DC2				.0137
High	18	9	49.4‡
Low	32	25	21.9‡

P values determined by log rank.

Patient survival 1000 days after transplantation.

Relapse-free survival 1000 days after transplantation.

aGVHD-free survival 100 days after transplantation.